NL-OMON35623招募中不适用
Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients - AIRCo study
Medisch Centrum Alkmaar0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age between 18 and 75 year
- •- Colon cancer patients scheduled for elective open abdominal surgery
- •- Capable of giving informed consent
排除标准
- •- Patients who are participating in another clinical trial
- •- Unable to receive oral intake
- •- Major malabsorption disorder of the gut
- •- Patients with diabetes mellitus
- •- Use of certain medication: thyroid medication, corticosteroids, diuretic medication
- •- BMI above 30 kg/m2
- •- Known bleeding disorders or increased PTT and/or APTT
研究者
相似试验
Unknown
不适用
Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma PatientsColon CarcinomaNCT00922688Medical Center Alkmaar30
进行中（未招募）
不适用
Dipeptide Alanyl Glutamine Prevents Postoperative Insulin Resistance in Colon Carcinoma Patients - AIRCo studyEUCTR2008-007748-33-NLForeest Medical School20
进行中（未招募）
不适用
Eficacia del dipéptido N(2)-L-Alanil-L-glutamina en los pacientes traumáticos ingresados en la UCI: estudio piloto, prospectivo, aleatorizado y doble ciegoEUCTR2009-017353-36-ESJon Perez Barcena
招募中
不适用
Effect of Supplementation of a Protein specific to body composition in the vein and observation of blood values and mortality in ICU patients after abdominal surgerynutritional and metabolic diseasesendocrine, nutritional and metabolic diseasesRBR-4jx82pEliseuda Marinho da Silva
Unknown
2 期
Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study.Trauma ICU PatientsNCT01250782Hospital Universitari Son Dureta150